NO972798L - Intravaginale medikamentleveringsanordninger for administrasjon av 17<beta>-östradiolforlöpere - Google Patents

Intravaginale medikamentleveringsanordninger for administrasjon av 17<beta>-östradiolforlöpere

Info

Publication number
NO972798L
NO972798L NO972798A NO972798A NO972798L NO 972798 L NO972798 L NO 972798L NO 972798 A NO972798 A NO 972798A NO 972798 A NO972798 A NO 972798A NO 972798 L NO972798 L NO 972798L
Authority
NO
Norway
Prior art keywords
beta
administration
drug delivery
delivery devices
intravaginal drug
Prior art date
Application number
NO972798A
Other languages
English (en)
Other versions
NO972798D0 (no
NO316707B1 (no
Inventor
Allen Mcclay
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Publication of NO972798D0 publication Critical patent/NO972798D0/no
Publication of NO972798L publication Critical patent/NO972798L/no
Publication of NO316707B1 publication Critical patent/NO316707B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO19972798A 1994-12-19 1997-06-17 Intravaginal medikamentleveringsanordning, fremgangsmate for fremstilling derav samt anvendelse NO316707B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IES940976 1994-12-19
IES950247 1995-04-05
PCT/IE1995/000063 WO1996019196A1 (en) 1994-12-19 1995-12-19 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS

Publications (3)

Publication Number Publication Date
NO972798D0 NO972798D0 (no) 1997-06-17
NO972798L true NO972798L (no) 1997-08-19
NO316707B1 NO316707B1 (no) 2004-04-13

Family

ID=26319777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972798A NO316707B1 (no) 1994-12-19 1997-06-17 Intravaginal medikamentleveringsanordning, fremgangsmate for fremstilling derav samt anvendelse

Country Status (19)

Country Link
US (1) US5855906A (no)
EP (1) EP0799025B1 (no)
JP (1) JPH10510825A (no)
CN (1) CN1138526C (no)
AR (1) AR002010A1 (no)
AT (1) ATE178204T1 (no)
AU (1) AU692659B2 (no)
CA (1) CA2207622C (no)
DE (1) DE69508791T2 (no)
DK (1) DK0799025T3 (no)
ES (1) ES2133841T3 (no)
FI (1) FI119414B (no)
GR (1) GR3030614T3 (no)
IL (1) IL116433A (no)
NO (1) NO316707B1 (no)
NZ (1) NZ298490A (no)
PE (1) PE62796A1 (no)
TR (1) TR199501599A2 (no)
WO (1) WO1996019196A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
AU741482B2 (en) * 1997-05-07 2001-11-29 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6811549B2 (en) * 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
EP1494646B2 (en) * 2002-03-27 2017-10-04 Warner Chilcott (Ireland) Limited Intravaginal matrix drug delivery devices
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
JP4898431B2 (ja) * 2003-04-29 2012-03-14 ザ ジェネラル ホスピタル コーポレイション 複数薬物の持続放出のための方法およびデバイス
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
EP1853221A2 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
JP5265359B2 (ja) 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー 膀胱内薬物送達デバイスおよび方法
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
JP5137841B2 (ja) 2005-10-13 2013-02-06 シンセス ゲーエムベーハー 薬物含浸容器
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
ES2696999T3 (es) * 2007-06-26 2019-01-21 Allergan Pharmaceuticals Int Ltd Dispositivos de administración intravaginal de medicamentos para la administración de macromoléculas y medicamentos solubles en agua
US9586035B2 (en) * 2007-12-11 2017-03-07 Massachusetts Institute Of Technology Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
EA201170297A1 (ru) 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
EP2437684B1 (en) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Anterior segment drug delivery
AU2010265863C1 (en) 2009-06-26 2012-11-01 Taris Biomedical Llc Implantable drug delivery devices and methods of making the same
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CA2823783C (en) 2011-01-10 2023-03-21 Taris Biomedical, Inc. Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
RU2598057C2 (ru) 2011-02-04 2016-09-20 ТАРИС Биомедикал ЛЛК Имплантируемое устройство для контролируемого высвобождения лекарственного средства с низкой растворимостью
CA2848397C (en) 2011-09-14 2022-04-26 Forsight Vision5, Inc. Ocular insert apparatus and methods
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
WO2014066775A1 (en) 2012-10-26 2014-05-01 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
HUE072250T2 (hu) 2013-03-15 2025-11-28 Taris Biomedical Llc Gyógyszeradagoló eszközök gyógyszeráteresztõ résszel
BR112015032045B1 (pt) 2013-06-21 2020-06-09 Depuy Synthes Products Inc corpo flexível, método para formar um filme multicamadas para uso em combinação com um dispositivo médico implantável, sistema de armazenamento de filme e sistema para tratamento ortopédico
ES2956840T3 (es) 2013-08-19 2023-12-29 Taris Biomedical Llc Dispositivos de administración de fármacos de múltiples unidades
CN104546668B (zh) * 2013-10-23 2019-03-05 国家卫生计生委科学技术研究所 液体硅橡胶为载体的药物缓控释系统的制备及应用
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN112494195A (zh) * 2014-04-01 2021-03-16 保利医学公司 避孕装置及相关装置
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
CN114573654B (zh) * 2020-12-01 2025-09-12 北京奇明达企业管理有限公司 17-O-乙酰-17-β雌二醇的自组装的三聚体、其制备、活性和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices

Also Published As

Publication number Publication date
WO1996019196A1 (en) 1996-06-27
US5855906A (en) 1999-01-05
FI972579A0 (fi) 1997-06-17
IL116433A (en) 2002-02-10
CN1170353A (zh) 1998-01-14
EP0799025B1 (en) 1999-03-31
ATE178204T1 (de) 1999-04-15
FI119414B (fi) 2008-11-14
GR3030614T3 (en) 1999-10-29
EP0799025A1 (en) 1997-10-08
AU692659B2 (en) 1998-06-11
DK0799025T3 (da) 1999-10-18
NO972798D0 (no) 1997-06-17
ES2133841T3 (es) 1999-09-16
DE69508791D1 (de) 1999-05-06
CA2207622A1 (en) 1996-06-27
NZ298490A (en) 1999-11-29
PE62796A1 (es) 1996-12-28
NO316707B1 (no) 2004-04-13
CA2207622C (en) 2006-10-17
JPH10510825A (ja) 1998-10-20
FI972579L (fi) 1997-06-17
CN1138526C (zh) 2004-02-18
TR199501599A2 (tr) 1996-07-21
DE69508791T2 (de) 1999-12-02
AU4399196A (en) 1996-07-10
IL116433A0 (en) 1996-03-31
AR002010A1 (es) 1998-01-07

Similar Documents

Publication Publication Date Title
NO972798D0 (no) Intravaginale medikamentleveringsanordninger for administrasjon av 17&lt;beta&gt;-östradiolforlöpere
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
MX9101175A (es) Composicion farmaceutica para administracion nasal
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
FI971776A7 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
NO975931D0 (no) Blanding for administrering av medikament
IT8348149A0 (it) Formulazione farmaceutica di clometacina per somministrazione orale eprocedimento di preparazione
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
FI955310L (fi) Farmaseuttinen koostumus flavonoidien antamiseksi oraalisesti
FI970331L (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
PT835103E (pt) Nanoparticulas para administracao oral de agentes farmaceuticos de baixa solubilidade
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
FI97944B (fi) Vaikuttavaa ainetta luovuttava laite
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
FR2660192B1 (fr) Formulation liposomiales pour l&#39;administration topique ou vaginale de medicaments.
FI891069A7 (fi) Suun kautta annettava järjestelmä vaikuttavan aineen säädettyä vapautumista varten
ZA9510787B (en) Intravaginal drug delivery devices for the administration of 17 beta-oestradiol precursors
PT785794E (pt) Composicoes entericas revestidas de derivados de 1,5-benzodiazepina tendo actividade antagonistica ou agonistica de cck
AU3961693A (en) Compositions and devices for the intrauterine administration of drugs
FR2702960B1 (fr) Leurre pour l&#39;administration orale de médicaments vétérinaires.
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
FR2602680B1 (fr) Compositions pharmaceutiques pour l&#39;administration par voie nasale
FR2725133B1 (fr) Composition pharmaceutique de fantofarone pour administration orale
SE9000204D0 (sv) Implantabel anordning foer lokal administration av laekemedel
GB9017999D0 (en) Device for the administration of pharmacologically active substances